Merci beaucoup for your frankness on your comments.
I want to do one follow-up question, and then I want to move on. In baseball, there's an analogy that you hit the ball towards the gap, and in Canada we have a gap in our coverage for pharmacare, if you want to use that term.
There was a report in the last two or three days from the Macdonald-Laurier Institute about the type of program we could possibly implement. I think that almost 75% of Canadians have a great program, and I personally don't want the New Zealand model, which I know other parties favour, because their coverage of the formulary isn't very good. You don't get the good medicines. You don't get the most up-to-date medicines. It's good populist rhetoric, but it's actually not good policy.
With your global footprint and knowledge, especially in Europe, I would like to hear your company's view with regard to how we cover those Canadians who don't have coverage.